Abstract:ABSTRACT Candida albicans is an opportunistic human fungal pathogen that causes common superficial mycoses in healthy populations and invasive disease in immunocompromised individuals. The fungus employs several virulence traits to cause disease in humans, including its ability to transition from yeast to filamentous morphologies. Previous work found that genetic or pharmacological inhibition of the dual-specificity tyrosine-phosphorylation regulated kinase (DYRK) Yak1 blocks C. albicans morphogenesis and biofilm formation. Here, we expand on this work to provide mechanistic insights into how Yak1 governs this important virulence trait. First, we establish that Yak1 acts either downstream or parallel to protein kinase A (PKA) to regulate filamentation in response to diverse inducing cues. Furthermore, its importance in governing filamentous growth is dependent on core transcriptional regulators, such as Efg1 and Flo8. We also report that hyperactivation of the Ras1/cAMP/PKA pathway under elevated, host-relevant concentrations of CO 2 bypasses the requirement for Yak1 in the yeast-to-filament transition. Seeking to identify the factor(s) that mediates filamentation under elevated CO 2 , we found that in a yak1- mutant background, homozygous deletion of a predicted, but previously uncharacterized DYRK, POM1, blocks filamentation. Finally, we demonstrate that Yak1 is required for morphogenesis in a dermatitis model of C. albicans infection and that pharmacological inhibition of Yak1 with a beta-carboline also attenuates filamentation in the dermal tissue. Overall, this work characterizes the role of Yak1 in regulating C. albicans morphogenesis, identifies an undescribed role for Pom1 in the yeast-to-filament transition, and suggests that inhibition of Yak1 may serve as a therapeutic strategy to combat C. albicans dermatitis. IMPORTANCE Candida albicans is an opportunistic human fungal pathogen that frequently causes life-threatening infections in immunocompromised individuals. To cause disease, the fungus employs several virulence traits, including its ability to transition between yeast and filamentous states. Previous work identified a role for the kinase Yak1 in regulating C. albicans filamentation. Here, we demonstrate that Yak1 regulates morphogenesis through the canonical cAMP/PKA pathway and that this regulation is environmentally contingent, as host-relevant concentrations of CO 2 bypass the requirement of Yak1 for C. albicans morphogenesis. We show a related kinase, Pom1, is important for filamentation in the absence of Yak1 under these host-relevant conditions, as deletion of both genes blocked filamentous growth under all conditions tested. Finally, we demonstrate that Yak1 is required for filamentation in a mouse model of C. albicans dermatitis using genetic and pharmacological approaches. Overall, our results expand our understanding of how Yak1 regulates an important virulence trait in C. albicans .

A Single Gene Mutation Underpins Metabolic Adaptation and Acquisition of Filamentous Competence in the Emerging Fungal Pathogen Candida Auris

Filamentation in Candida Auris, an Emerging Fungal Pathogen of Humans: Passage Through the Mammalian Body Induces a Heritable Phenotypic Switch

A gain-of-function mutation in zinc cluster transcription factor Rob1 drives Candida albicans adaptive growth in the cystic fibrosis lung environment

Filamentous Growth is a General Feature of Candida Auris Clinical Isolates.

Rapid Evolution of an Adaptive Multicellular Morphology of Candida Auris During Systemic Infection

Regulation of Filamentation in the Human Fungal Pathogen Candida Tropicalis

Roles of Candida Albicans Gat2, a GATA-Type Zinc Finger Transcription Factor, in Biofilm Formation, Filamentous Growth and Virulence

Ume6-dependent pathways of morphogenesis and biofilm formation in Candida auris

In vivo RNA sequencing reveals a crucial role of Fus3-Kss1 MAPK pathway in Candida glabrata pathogenicity

The Mitochondrial Protein Mcu1 Plays Important Roles in Carbon Source Utilization, Filamentation, and Virulence in Candida Albicans

Genetic Analysis of Candida albicans Filamentation by the Iron Chelator BPS Reveals a Role for a Conserved Kinase—WD40 Protein Pair

A correlative study of the genomic underpinning of virulence traits and drug tolerance of Candida auris

Yeast and filamentous Candida auris stimulate distinct immune responses in the skin

Genetic modification of Candida maltosa, a non-pathogenic CTG species, reveals EFG1 function

Candida albicans gains azole resistance by altering sphingolipid composition

Lactic Acid Bacteria Differentially Regulate Filamentation in Two Heritable Cell Types of the Human Fungal Pathogen Candida Albicans

Alteration of β-glucan in the emerging fungal pathogen Candida auris leads to immune evasion and increased virulence

Metabolic reprogramming during Candida albicans planktonic-biofilm transition is modulated by the transcription factors Zcf15 and Zcf26

Evolutionary dynamics in gut-colonizing Candida glabrata during caspofungin therapy: Emergence of clinically important mutations in sphingolipid biosynthesis

The Transcriptional Response of Candida albicans to Weak Organic Acids, Carbon Source, and MIG1 Inactivation Unveils a Role for HGT16 in Mediating the Fungistatic Effect of Acetic Acid

DYRK-family kinases regulate Candida albicans morphogenesis and virulence through the Ras1/PKA pathway